课题基金 / 基金详情

Intestinal PepT1 in Health and Disease

Intestinal PepT1 in Health and Disease
肠道 PepT1 在健康和疾病中的作用
批准号:
8413086
负责人:
DIDIER MERLIN
金额:
$24.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2012-07-31

项目摘要

项目成果

DIDIER MERLIN的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary PepT1 is mainly expressed in brush-border membranes of enterocytes in the small intestine. PepT1 has a differential pattern of expression in the small intestine. Along the vertical axis, PepT1 is most abundant at the villous tip, with expression decreasing towards the crypt, whereas along the longitudinal axis, the PepT1 level increases from the duodenum to the ileum. However, PepT1 mRNA or protein is expressed at very low levels or is not expressed in the colon. Consistent with these findings, hPepT1 is expressed in the small intestine-like cell line Caco2-BBE but not in the colonic-like cell line HT29-Cl.19A. Although PepT1 is not normally expressed in colonic epithelial cells, we and others have reported that hPepT1 is expressed in epithelial cells of the chronically inflamed colon and in the colonic mucosa of patients with shortbowel syndrome, confirming that hPepT1 expression is induced in colonic epithelial cells under pathological conditions. Recently, we have demonstrated that hPepT1 transports the antiinflammatory tripeptide KPV that has been shown to reduce intestinal inflammation. Our main hypothesis is that regulated PepT1 expression along the crypt¿villus axis is required for its physiological role in nutrient absorption, whereas aberrant expression in the colon under pathological conditions modulates disease manifestation. The first aim of our proposal will investigate the regulatory role of miR-619 in PepT1 differential expression along the crypt¿villus axis and the sequence target of miR-619 on the PepT1 gene. Second, we aim to determine the roles of the transcription factor Cdx2 and miR-619 in determining the levels of colonic PepT1 expression and will assess its effects on colonic epithelial functions in the third aim. It is important to understand the regulation of PepT1 expression in the small intestine because PepT1 controls overall protein absorption via the PepT1-mediated di/tripeptide transport that is essential for individuals to remain healthy. In addition, the development of therapeutic strategies capable of controlling PepT1 expression could be important for enteral nutrition and PepT1-mediated drug delivery. Finally, it is also important to understand the transcriptional and post-transcriptional mechanisms by which PepT1 can be expressed in colonic epithelial cells and the pathophysiological consequences of this expression. The ultimate goal is to identify and develop therapeutic strategies to control abnormal PepT1 expression under pathological conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLR&D Research Career Scientist Award Application
  • 批准号:
    10516018
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    DIDIER MERLIN
  • 依托单位:
BLR&D Research Career Scientist Award Application
  • 批准号:
    10047290
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    DIDIER MERLIN
  • 依托单位:
BLR&D Research Career Scientist Award Application
  • 批准号:
    10293578
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    DIDIER MERLIN
  • 依托单位:
Small intestinal PepT1 expression plays a critical role in maintaining intestinal homeostasis and in shaping the gut microbiota
  • 批准号:
    10266018
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    DIDIER MERLIN
  • 依托单位:
国内基金
海外基金
PEPT1转运/CES2-CES1差异化激活淫羊藿素高效口服载体前药的研究
基于PEPT1和BPHL双靶点的淫羊藿素口服前药的设计与评价
  • 批准号:
    82374157
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    张天虹
  • 依托单位:
草鱼肠道NHE8协同PepT1转运小肽分子机制研究
  • 批准号:
    2023JJ40075
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    毛庄文
  • 依托单位:
肠道PEPT1靶向的程序化生物激活的帕拉米韦巯基二肽新型口服前药的研究
  • 批准号:
    82360705
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    31万元
  • 批准年份:
    2023
  • 负责人:
    孙勇兵
  • 依托单位: